TipRanks
Go Ultimate55% OFF

Karen Zaderej Insider Profile

4 Followers

Karen Zaderej, Director at EyePoint Pharmaceuticals, holds 49.10K shares in EyePoint Pharmaceuticals (Ticker: EYPT), holds 1.14M shares in AxoGen (Ticker: AXGN), holds 62.35K shares in Viveve Medical (Ticker: VIVE). Most recently, Karen Zaderej Bought ― shares of EyePoint Pharmaceuticals on Aug 18, 2026 for an estimated value of $52.26K.

Karen Zaderej's Trading History

EYPT
EyePoint Pharmaceuticals
Aug 18, 2026DirectorInformative Buy52.26K$17.09K
AXGN
AxoGen
Mar 25, 2024CEO, DirectorUninformative Buy545.60K$56.47M
VIVE
Viveve Medical
Jul 02, 2019DirectorUninformative Buy――

You May Also Like

Karen Zaderej insider profile FAQ

What is the percentage of profitable transactions made by Karen Zaderej?
The percentage of profitable transactions made by Karen Zaderej is 83%.
What is the average return per transaction made by Karen Zaderej?
The average return per transaction made by Karen Zaderej is 36.40%.
What stocks does Karen Zaderej hold?
Karen Zaderej holds: EYPT, AXGN, VIVE stocks.
What was Karen Zaderej’s latest transaction?
Karen Zaderej’s latest transaction was an Informative Buy of $52.26K.
What was Karen Zaderej's most profitable transaction?
Karen Zaderej’s most profitable transaction was an Informative Buy of AXGN stock on October 14, 2016. The return on the trade was 122.40%.
What is Karen Zaderej's role in EyePoint Pharmaceuticals?
Karen Zaderej's role in EyePoint Pharmaceuticals is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.